These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 1733562)
1. Reaction product inactivation of aryl sulfotransferase IV following electrophilic substitution by the sulfuric acid ester of N-hydroxy-2-acetylaminofluorene. Ringer DP; Norton TR; Self RR Carcinogenesis; 1992 Jan; 13(1):107-12. PubMed ID: 1733562 [TBL] [Abstract][Full Text] [Related]
2. 2-Acetylaminofluorene-mediated alteration in the level of liver arylsulfotransferase IV during rat hepatocarcinogenesis. Ringer DP; Norton TR; Howell BA Cancer Res; 1990 Sep; 50(17):5301-7. PubMed ID: 2386938 [TBL] [Abstract][Full Text] [Related]
3. Evidence of two separate mechanisms for the decrease in aryl sulfotransferase activity in rat liver during early stages of 2-acetylaminofluorene-induced hepatocarcinogenesis. Ringer DP; Howell BA; Norton TR; Woulfe GW; Duffel MW; Kosanke SD Mol Carcinog; 1994 Jan; 9(1):2-9. PubMed ID: 8297481 [TBL] [Abstract][Full Text] [Related]
4. Self-catalyzed irreversible inactivation of rat hepatic aryl sulfotransferase IV by N-hydroxy-2-acetylaminofluorene. Mangold BL; Erickson J; Lohr C; McCann DJ; Mangold JB Carcinogenesis; 1990 Sep; 11(9):1563-7. PubMed ID: 2401045 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a complementary DNA for rat liver aryl sulfotransferase IV and use in evaluating the hepatic gene transcript levels of rats at various stages of 2-acetylaminofluorene-induced hepatocarcinogenesis. Yerokun T; Etheredge JL; Norton TR; Carter HA; Chung KH; Birckbichler PJ; Ringer DP Cancer Res; 1992 Sep; 52(17):4779-86. PubMed ID: 1511441 [TBL] [Abstract][Full Text] [Related]
6. Phenol sulfotransferase. II. Inactivation by phenylglyoxal, N-ethylmaleimide and ribonucleotide 2',3'-dialdehydes. Borchardt RT; Schasteen CS; Wu SE Biochim Biophys Acta; 1982 Nov; 708(3):280-93. PubMed ID: 6959651 [TBL] [Abstract][Full Text] [Related]
7. Affinity labeling of aryl sulfotransferase IV. Identification of a peptide sequence at the binding site for 3'-phosphoadenosine-5'-phosphosulfate. Zheng Y; Bergold A; Duffel MW J Biol Chem; 1994 Dec; 269(48):30313-9. PubMed ID: 7982943 [TBL] [Abstract][Full Text] [Related]
8. Sulphonation of N-hydroxy-2-acetylaminofluorene by human dehydroepiandrosterone sulphotransferase. Lewis AJ; Otake Y; Walle UK; Walle T Xenobiotica; 2000 Mar; 30(3):253-61. PubMed ID: 10752640 [TBL] [Abstract][Full Text] [Related]
10. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites. Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585 [TBL] [Abstract][Full Text] [Related]
11. Role of sulfation in the formation of DNA adducts from N-hydroxy-2-acetylaminofluorene in rat liver in vivo. Inhibition of N-acetylated aminofluorene adduct formation by pentachlorophenol. Meerman JH; Beland FA; Mulder GJ Carcinogenesis; 1981; 2(5):413-6. PubMed ID: 7273322 [TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of N-hydroxy-2-acetylaminofluorene sulfotransferase from rat liver. Wu SG; Straub KD J Biol Chem; 1976 Nov; 251(21):6529-36. PubMed ID: 10300 [TBL] [Abstract][Full Text] [Related]
13. Mass spectrometric investigation of the mechanism of inactivation of hamster arylamine N-acetyltransferase 1 by N-hydroxy-2-acetylaminofluorene. Guo Z; Wagner CR; Hanna PE Chem Res Toxicol; 2004 Mar; 17(3):275-86. PubMed ID: 15025497 [TBL] [Abstract][Full Text] [Related]
14. Isolation and expression of a cDNA encoding a male-specific rat sulfotransferase that catalyzes activation of N-hydroxy-2-acetylaminofluorene. Nagata K; Ozawa S; Miyata M; Shimada M; Gong DW; Yamazoe Y; Kato R J Biol Chem; 1993 Nov; 268(33):24720-5. PubMed ID: 8227031 [TBL] [Abstract][Full Text] [Related]
15. Production of a dimer of 2-acetylaminofluorene during the sulfation of N-hydroxy-2-acetylaminofluorene in vitro. Andrews LS; Pohl LR; Hinson JA; Fisk CL; Gillette JR Drug Metab Dispos; 1979; 7(5):296-300. PubMed ID: 40769 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of aryl sulfotransferase by carboxylic acids. Rao SI; Duffel MW Drug Metab Dispos; 1991; 19(2):543-5. PubMed ID: 1676667 [TBL] [Abstract][Full Text] [Related]
17. N-sulfoöxy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of N-hydroxy-2-acetylaminofluorene in the livers of infant male C57BL/6J x C3H/HeJ F1 (B6C3F1) mice. Lai CC; Miller JA; Miller EC; Liem A Carcinogenesis; 1985 Jul; 6(7):1037-45. PubMed ID: 3860305 [TBL] [Abstract][Full Text] [Related]
18. Interaction of nucleophiles with the enzymatically-activated carcinogen, N-hydroxy-2-acetylaminofluorene, and with the model ester, N-acetoxy-2-acetylaminofluorene. Smith BA; Gutmann HR; Springfield JR Carcinogenesis; 1985 Feb; 6(2):271-7. PubMed ID: 3971491 [TBL] [Abstract][Full Text] [Related]
19. Molecular cloning, expression, and characterization of novel human SULT1C sulfotransferases that catalyze the sulfonation of N-hydroxy-2-acetylaminofluorene. Sakakibara Y; Yanagisawa K; Katafuchi J; Ringer DP; Takami Y; Nakayama T; Suiko M; Liu MC J Biol Chem; 1998 Dec; 273(51):33929-35. PubMed ID: 9852044 [TBL] [Abstract][Full Text] [Related]
20. Characterization of hamster recombinant monomorphic and polymorphic arylamine N-acetyltransferases: bioactivation and mechanism-based inactivation studies with N-hydroxy-2-acetylaminofluorene. Sticha KR; Bergstrom CP; Wagner CR; Hanna PE Biochem Pharmacol; 1998 Jul; 56(1):47-59. PubMed ID: 9698088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]